Combined l-thyroxine and l-triiodothyronine replacement therapy in congenital hypothyroidism;Kombinált l-tiroxin és l-trijód-tironin hormonpótlás congenitalis hypothyreosisban

Orvosi Hetilap

Volumn 154, Issue 19, 2013, Pages 738-744

  Péter, Ferenc ^a   Muzsnai, Ágota ^a  

^a ST JOHN'S HOSPITAL   (Hungary)

Author keywords

combined therapy with l thyroxine and l triiodothyronine; congenital hypothyroidism

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HYPOTHYROIDISM; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; SCHOOL CHILD; SUBSTITUTION THERAPY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

CONGENITAL HYPOTHYROIDISM; DRUG THERAPY, COMBINATION; FEEDBACK, PHYSIOLOGICAL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HUNGARY; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 84877250561     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2013.29599     Document Type: Article

References (30)

1. Medvei, V. C.: The history of clinical endocrinology. The Parthenon Publishing Group, Lancaster-New York, 1993, 232, 368.
2. Pilo, A., Iervasi, G., Vitek, F., et al.: Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis. Am. J. Physiol., 1990, 258, E715-E726. (Pubitemid 20142356)
3. Escobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., et al.: Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J. Clin. Invest., 1995, 96, 2828-2838.
4. Escobar-Morreale H. F., Escobar del Rey, F., Obregón, M. J., et al.: Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology, 1996, 137, 2490-2502. (Pubitemid 26155786)
5. Buneviius, R., Kažanaviius, G., Žalinkeviius, R., et al.: Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N. Engl. J. Med., 1999, 340, 424-429.
6. Appelhof, B. C., Fliers, E., Wekking, E. M., et al.: Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J. Clin. Endocrinol. Metab., 2005, 90, 2666-2674. (Pubitemid 40686307)
7. Nygaard, B., Jensen E. W., Kvetny, J., et al.: Effect of combination therapy with thyroxine (T4) and 3,5,3'-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a doubleblind, randomized cross-over study. Eur. J. Endocrinol., 2009, 161, 895-902.
8. Wiersinga, W. M.: Do we need still more trials on T4 and T3 combination therapy in hypothyroidism Eur. J. Endocrinol., 2009, 161, 955-959.
9. Gullo, D., Latina, A., Frasca, F., et al.: Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PloS One, 2011, 6, e22552.
10. Biondi, B., Wartofsky, L.: Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism. J. Clin. Endocrinol. Metab., 2012, 97, 2256-2271.
11. Perros, P.: European Thyroid Association Guidelines on L-T4 + L-T3 combination for hypothyroidism: a weary step in the right direction. Eur. Thyroid J., 2012, 1, 51-54.
12. Wiersinga, W. M., Duntas, L., Fadeyev, V., et al.: 2012 ETA Guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur. Thyroid J., 2012, 1, 55-71.
13. Muzsnai, Á., Péter, F., Blatniczky, L., et al.: The fi rst 13 year of the congenital hypothyroidism screening. [A veleszületett hypothyreosis szrvizsgálatának els 13 éve.] Gyermekgyógyászat, 1997, 48, 133-135. [Hungarian]
14. Péter, F., Muzsnai, Á., Gráf, R.: Congenital hypothyroidism. In: Potlukova, E. (ed.): Current topics in hypothyroidism with focus on development. InTech-Open Access Publisher, Rijeka, 2013, 65-89.
15. Péter, F., Muzsnai, A.: Congenital disorders of the thyroid: hypo/hyper. Endocrinol. Metab. Clin. North Am., 2009, 38, 491-507.
16. Péter, F., Blatniczky, L., Breyer, H.: About the form and replacement dose of thyroid hormones in the treatment of congenital hypothyroidism CH. In: Delange, F., Fisher, D. A., Glinoer, D. (eds).): Research in Congenital Hypothyroidism. Plenum Press, New York-London. 1988.
17. Muzsnai, Á.: Some aspects to optimize the hormone substitution in congenital hypothyroidism. Dissertation. [A hormon substitutio optimalizálásának néhány szempontja congenitalis hypothyreosisban.] Disszertáció, Budapest, 1991. [Hungarian]
18. Russel, W., Harrison, R. F., Smith, N., et al.: Free triiodothyronine has a distinct circadian rhythm that is delayed but parallels thyrotropin levels. J. Clin. Endocrinol. Metab., 2008, 93, 2300-2306. (Pubitemid 351831551)
19. Fisher, D. A., Schoen, E. J., La Franchi, S., et al.: The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism. J. Clin. Endocrinol. Metab., 2000, 85, 2722-2727. (Pubitemid 32269141)
20. Kara, C., Ocal, G., Berberolu, M., et al.: Persistently raised thyroid stimulating hormone in adequately treated congenital hypothyroidism on long-term follow-up. J. Pediatr. Endocrinol. Metab., 2008, 21, 251-256. (Pubitemid 351559862)
21. Rucz, K., Bajnok, L., Bódis, B., et al.: Syndrome of inappropriate secretion of TSH-case reports. [A nem megfelel TSH-szekréció szindrómáról három eset kapcsán.] Magy. Belorv. Arch., 2009, 62, 404-409. [Hungarian]
22. Fish, L. H., Schwartz, H. L., Cavanaugh, J., et al.: Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism: role of triiodothyronine in pituitary feedback in humans. N. Engl. J. Med. 1987, 316, 764-770. (Pubitemid 17046084)
23. Arnaud-Lopez, L., Usala, G., Ceresini, G., et al.: Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am. J. Hum. Genet., 2008, 82, 1270-1280.
24. Taylor, P. N., Panicker, V., Sayers, A., et al.: A meta-analysis of the associations between common variation in the PDE8B gene and thyroid hormone parameters, including assessment of longitudinal stability of associations over time and effect of thyroid hormone replacement. Eur. J. Endocrinol., 2011, 164, 773-780.
25. Medici, M., van der Deure, W. M., Verbiest, M., et al.: A large-scale association analysis of 68 thyroid hormone pathway genes with serum TSH and FT4 levels. Eur. J. Endocrinol., 2011, 164, 781-788.
26. Panicker, V., Saravanan, P., Vaidya, B., et al.: Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J. Clin Endocrinol. Metab., 2009, 94, 1623-1629.
27. Torlontano, M., Durante, C., Torrente, I. et al.: Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients. J. Clin. Endocrinol. Metab., 2008, 93, 910-913. (Pubitemid 351398572)
28. Heemstra, K. A., Hoftijzer, H. C., van der Deure, W. M., et al.: Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis. Clin. Endocrinol. (Oxf.), 2009, 71, 279-283.
29. Butler, P. W., Smith, S. M., Linderman, J. D., et al.: The Thr92Ala 5' type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone-stimulation test: a pharmacogenomic study. Thyroid, 2010, 20, 1407-1412.
30. Henneman, G., Docter, R., Visser, T. J., et al.: Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism. Thyroid, 2004, 14, 271-275. (Pubitemid 38569276)